EUVIMEDEUVIMED entdecken
Crossref

A pH-responsive silver nanoparticle platform overcomes MEK inhibitor resistance in neurofibroma via triacsin C-mediated lipid metabolic reprogramming

Jiang Xu, Longyan Liu, Shuheng Liu, Zesong He, Wei Meng

Apoptosis · 2026-06 · 31 (6)

DOI: 10.1007/s10495-026-02344-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, online erschienen am 24.05.2026. Verfasst von Jiang Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, No. 17 Yongwai Zhengjie, Donghu District, Nanchang, 330006, Jiangxi…. Hauptthemen laut MEDLINE: Silver, Metal Nanoparticles, Lipid Metabolism, Drug Resistance, Neoplasm. Die Arbeit nennt 84 Literaturangaben. Gefördert von: Science and Technology Support Plan of Jiangxi Provincial Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To overcome resistance to MEK inhibitors such as selumetinib in neurofibroma, we developed a metabolism-targeted nanotherapeutic based on a pH-responsive silver nanoparticle platform (AgNP-PEG-TC) for delivering Triacsin C (TC), an inhibitor of long-chain acyl-CoA synthetases, to disrupt tumor-associated lipid metabolism. AgNP-PEG-TC was synthesized and characterized for its physicochemical properties, drug-loading efficiency, and pH-responsive release behavior. Its antitumor effects were assessed in human neurofibroma cells, including selumetinib-resistant cells, and in normal Schwann cells by examining proliferation, apoptosis, migration, and invasion. In vivo therapeutic efficacy and biosafety were evaluated in neurofibroma xenograft models. Bulk RNA sequencing, lipidomics, and protein analyses were performed to investigate the underlying mechanisms. AgNP-PEG-TC demonstrated stable colloidal properties and successful pH-sensitive release. It selectively reduced neurofibroma cell growth, migration, and invasion while promoting apoptosis, with minimal effects on normal cells. In xenograft models, AgNP-PEG-TC significantly inhibited tumor growth and showed good biocompatibility. Multi-omics analyses indicated that its antitumor activity was associated with ACSL4 downregulation, remodeling of arachidonic-acid-enriched phospholipids, enhanced lipid peroxidation, and increased lipid-droplet accumulation, suggesting heightened ferroptosis susceptibility. Notably, AgNP-PEG-TC synergized with MEK inhibitors and restored antitumor responses in resistant neurofibroma cells. These findings establish a metabolism-nanotechnology synergy in which AgNP-PEG-TC-mediated ACSL4 inhibition and lipid metabolic reprogramming resensitize MEK inhibitor-resistant neurofibromas to therapy. The platform functions as both a targeted drug carrier and a modulator of tumor lipid homeostasis, offering a promising combinatorial strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SilverMetal NanoparticlesLipid MetabolismDrug Resistance, NeoplasmProtein Kinase InhibitorsHumansAnimalsHydrogen-Ion ConcentrationMiceCell Line, TumorMetabolic ReprogrammingApoptosisXenograft Model Antitumor AssaysMice, NudeCell ProliferationCell MovementTriazenes

Stichwörter der Autor:innen

Combination therapyFerroptosisLipid metabolismMEK inhibitor resistanceNeurofibromaSilver nanoparticles

Substanzen

Silvertriacsin CProtein Kinase InhibitorsTriazenes

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, No. 17 Yongwai Zhengjie, Donghu District, Nanchang, 330006, Jiangxi Province, China.
  • Clinical Laboratory, Jiangxi Cancer Hospital, Nanchang, 330000, Jiangxi Province, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, No. 17 Yongwai Zhengjie, Donghu District, Nanchang, 330006, Jiangxi Province, China. ndyfy2298@ncu.edu.cn.

Förderung

  • Science and Technology Support Plan of Jiangxi Provincial Department of Health

Zitieren

APA

Xu, J., Liu, L., Liu, S., He, Z., & Meng, W. (2026). A pH-responsive silver nanoparticle platform overcomes MEK inhibitor resistance in neurofibroma via triacsin C-mediated lipid metabolic reprogramming. Apoptosis, 31(6). https://doi.org/10.1007/s10495-026-02344-9

Vancouver

Xu J, Liu L, Liu S, He Z, Meng W. A pH-responsive silver nanoparticle platform overcomes MEK inhibitor resistance in neurofibroma via triacsin C-mediated lipid metabolic reprogramming. Apoptosis. 2026;31(6). doi:10.1007/s10495-026-02344-9

BibTeX
@article{Xu2026,
  author = {Xu, Jiang and Liu, Longyan and Liu, Shuheng and He, Zesong and Meng, Wei},
  title = {A pH-responsive silver nanoparticle platform overcomes MEK inhibitor resistance in neurofibroma via triacsin C-mediated lipid metabolic reprogramming},
  journal = {Apoptosis},
  year = {2026},
  volume = {31},
  number = {6},
  doi = {10.1007/s10495-026-02344-9}
}
Kostenlos starten →